1-Methyl-2-[(6Z,9Z)-6,9-pentadecadiene]-4(1H)-quinolone
Catalog No: CFN91687
Methyl-2-[(6Z,9Z)-6,9-pentadecadienyl]-4(1H)-quinolone9 is an antagonist of angiotensin II receptor (IC50=48.2 μM). Methyl-2-[(6Z,9Z)-6,9-pentadecadienyl]-4(1H)-quinolone9 is a quinolone alkaloid from Evodia rutaecarpa.1-methyl-2-[(6Z,9Z)-6,9-pentadecadienyl]-4(1H)-quinolone is an MAO-B inhibitor.1-Methyl-2-[(6Z,9Z)-6,9-pentadecadiene]-4(1H)-quinolone exhibits potent anti-Helicobacter pylori activity with a minimum inhibitory concentration (MIC) value of 10-20 μg/ml. 1-Methyl-2-[(6Z,9Z)-6,9-pentadecadiene]-4(1H)-quinolone exhibits dose-dependent DGAT inhibition with IC 50 of 13.5 μ.
1-O-Acetylbritannilactone
Catalog No: CFN89438
1-O-Acetylbritannilactone has anticancer activity, it suppresses angiogenesis and lung cancer cell growth possibly via regulating the VEGFR-Src-FAK signaling, it also can combine with gemcitabine elicits a potent apoptosis of lung cancer cell. 1-O-Acetylbritannilactone may serve as a novel therapeutic intervention for various cardiovascular diseases, including chronic ischemia, by regulating VEGF signaling and modulating angiogenesis; it is a potent inhibitor of LPS-stimulated VSMC inflammatory responses through blockade of NF-kappaB activity and inhibition of inflammatory gene COX-2 expression. 1-O-Acetylbritannilactone may act as potent natural skin-lightening agents, it exhibits anti-melanogenic activity by suppression of tyrosinase expression via ERK and Akt signaling.